Free Trial
CVE:NTB

12942 (NTB.V) (NTB) Stock Price, News & Analysis

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)
Free NTB Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
31,049 shs
Average Volume
315,395 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About 12942 (NTB.V)

Neptune Technologies & Bioressources Inc. (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and Acasti Pharma Inc. Its Neptune produces and commercializes nutraceutical products. Its Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. It produces omega-3 PUFAs through its patented process of extracting oils from Antartic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune’s distributors who commercialize them under their private label primarily in the United States, European and Australian nutraceutical markets. The Company’s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO).

NTB Stock News Headlines

February 9, 2024 | wsj.com
Bank of Butterfield Ltd.
November 23, 2023 | seekingalpha.com
NTB Dividend Yield Grade
April 25, 2024 | The TradingPub (Ad)
At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
October 19, 2023 | time.com
Ntb Coupons
February 19, 2023 | finance.yahoo.com
NYSE U.S. 100 Index (^NY)
See More Headlines
Receive NTB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 12942 (NTB.V) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/15/2014
Today
4/25/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Finance
Industry
Regional Banks
Sub-Industry
N/A
Current Symbol
CVE:NTB
CUSIP
N/A
CIK
N/A
Web
neptunekrilloil.com
Phone
+1-450-6872262
Fax
N/A
Employees
1,134
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • John Moretz
    Chairman of the Board
  • James Stuart Hamilton
    President, Chief Executive Officer, Director
  • Mario Paradis
    Chief Financial Officer
  • Michel Timperio
    Senior Vice President of Sales - Global Sales
  • Pierre Lemieux Ph.D.
    Chief Operating Officer of Acasti
  • Jean-Daniel Belanger
    Corporate Secretary and Director - Corporate Affairs
  • Harlan W. Waksal M.D. (Age 61)
    Director
  • Valier Boivin
    Independent Director
  • Ronald Denis
    Independent Director
  • Adrian Taylor Montgomery
    Independent Director

Key Competitors

View All Competitors

NTB Stock Analysis - Frequently Asked Questions

How were 12942 (NTB.V)'s earnings last quarter?

12942 (NTB.V) (CVE:NTB) announced its earnings results on Tuesday, July, 15th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.02. The biotechnology company had revenue of $3.69 million for the quarter, compared to analysts' expectations of $7.31 million.

Is 12942 (NTB.V) a good dividend stock?

12942 (NTB.V) (CVE:NTB) pays an annual dividend of C$1.52 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of 12942 (NTB.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 12942 (NTB.V) investors own include ACADIA Pharmaceuticals (ACAD), Adverum Biotechnologies (ADVM), Aimmune Therapeutics (AIMT), ANI Pharmaceuticals (ANIP), AxoGen (AXGN), Biohaven (BHVN), bluebird bio (BLUE), Blueprint Medicines (BPMC), Calithera Biosciences (CALA) and Codexis (CDXS).

How do I buy shares of 12942 (NTB.V)?

Shares of NTB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:NTB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold